CVRS stock: buy or sell?
August 19th, 2019
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures.
Should I buy CVRS stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Corindus Vascular Robotics stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Corindus Vascular Robotics stock a buy?
Financial institutions and banks publish stock ratings everyday.Unfortunately, we couldn't detect any rating for CVRS stock for the last 30 days.
CVRS stock analysis
After climbing for 4 sessions, Monday Corindus Vascular Robotics stayed stable a lame -0.23%, closing at $4.26.
After climbing for 4 days, Monday Corindus Vascular Robotics stayed steady a lame -0.23%, closing at $4.26. Price climbed above $2.91 breaking the short term down trend. $2.91 should act now as a support and could be tested in the coming days. On Aug/8 CVRS price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.
Corindus Vascular Robotics shares remained steady -0.23% this week, ending at $4.26. Early August CVRS rocketed an astounding 44.16% in just one week. Late July CVRS plummed a hair-raising -14.64% in just one week.
Corindus Vascular Robotics stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Early January CVRS price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since late October 2018 when SMA20w and SMA40w crossed up, CVRS price gained $3.18 per share (294.44%).
CVRS stock price history
CVRS IPO was on August 18th, 2014 at $3.15 per share1. Since then, CVRS stock grew a 35.20%, with a yearly average of 7.00%. If you had invested $1,000 in CVRS stock in 2014, it would worth $352.00 today.
1: Adjusted price after possible price splits or reverse-splits.
CVRS stock historical price chart
CVRS stock reached 52-week highs on Aug/9 at $4.30, and all-time highs 2015-06-15 with a price of 4.58.
CVRS stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not detected any price target for Corindus Vascular Robotics stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter posting its last earnings report on November, Corindus Vascular Robotics . As soon as we get its posted EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw an impressive increase of 11.72% to $10.78 M dollars. When comparing 2018 vs 2017, similarly, profit margin (that is, the net income divided by revenues) skyrocketed a 29.06% to -324.54%. To have an updated picture of the financial situation of Corindus Vascular Robotics, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q3 that can be compared to 2018 fiscal year results. Annual Corindus Vascular Robotics TTM sales up to September 2018 were $10.30 and earnings were $-35.53 M USD. If we compare this TTM figures with the last reported annuality, we can review Corindus Vascular Robotics business evolution since December 2018: Annual turnover up to September, compared to lastest yearly report, declined an awful -4.48%. Regarding profit margin, Corindus Vascular Robotics plummed -20.43% to -324.54%
|2013||$0.90 M||-||$-14.69 M-1639.5%||-|
|2014||$36 M||3,917.86%||$0.00 M0.0%||-100.00%|
|2014||$2.98 M||-91.71%||$-24.54 M-822.7%||0.00%|
|2015||$2.73 M||-8.51%||$-28.76 M-1054.0%||17.20%|
|2016||$2.84 M||4.14%||$-33.08 M-1163.9%||15.00%|
|2017||$9.65 M||239.55%||$-34.12 M-353.6%||3.16%|
|2018||$11 M||11.72%||$-34.99 M-324.5%||2.54%|
|TTM||$10 M||-4.48%||$-35.53 M-345.0%||1.53%|
Quarterly financial resultsCorindus Vascular Robotics posted $2.96 M in sales for 2018-Q3, a 77.66% up compared to previous quarter. Reported quarter earnings marked $-7.60 million with a profit margin of -256.76%. Profit margin climbed a 338.37% compared to previous quarter when profit margin was -595.14%. When comparing sales to same quarter last year, Corindus Vascular Robotics sales marked an astounding increase and boosted a 21.98%. Looking back to recent quarterly results, Corindus Vascular Robotics posted 2 negative quarters in a row.
|2017-Q1||$1 M||-||$-9.89 M-1272.8%||-|
|2017-Q2||$2 M||190.86%||$-8.41 M-372.1%||-14.96%|
|2017-Q3||$2 M||7.30%||$-7.85 M-323.8%||-6.62%|
|2017-Q4||$4 M||72.78%||$-7.97 M-190.2%||1.50%|
|2018-Q1||$1 M||-64.56%||$-10.05 M-676.8%||26.08%|
|2018-Q2||$2 M||12.12%||$-9.91 M-595.1%||-1.40%|
|2018-Q3||$3 M||77.66%||$-7.60 M-256.8%||-23.35%|
|2018-Q4||$5 M||57.98%||$-7.44 M-159.1%||-2.11%|
Corindus Vascular Robotics ownershipWhen you are planning to invest in shares of a stock, it's worth to check its ownership structure.
Corindus Vascular Robotics shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 23.78% of all shares.
In case of Corindus Vascular Robotics stock, 45.96% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CVRS stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$815.0 M||$59.4 B|
|Total shares||191.3 M||1,390.0 M|
|Float shares||132.6 M||1,390.0 M|
|- Institutional holdings (%)||46.0%||93.4%|
|- Insider holdings (%)||23.8%||0.2%|
|Shares in short selling||0.0%||0.0%|
|Monday, August 19th, 2019|
|Day range||$4.25 - $4.27|
|Average true range||$0.25|
|50d mov avg||$3.06|
|100d mov avg||$2.70|
|200d mov avg||$1.99|
Corindus Vascular Robotics performanceTo measure stock performance is always good to compare with competitors or related stocks. We selected Array as the bechmarking frame for Corindus Vascular Robotics stock.